U. Dallas
Rankings
| Data year | Earned doctorates | Full-time graduate students | Total R&D expenditures | Research space | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rank | Percentile | Institutions ranked | Rank | Percentile | Institutions ranked | Rank | Percentile | Institutions ranked | Rank | Percentile | Institutions ranked | |||||
| 2023 | 382 | 17.6 | 459 | 566 | 17.5 | 679 | 888 | 3.8 | 914 | |||||||
| 2022 | 350 | 24.2 | 457 | 532 | 22.6 | 680 | 759 | 16.5 | 900 | |||||||
| 2021 | 363 | 19.6 | 447 | 501 | 28.3 | 691 | 864 | 5.8 | 908 | |||||||
| 2020 | 412 | 9.4 | 450 | 528 | 25.2 | 698 | ||||||||||
| 2019 | 361 | 20.1 | 447 | 539 | 23.5 | 697 | i | |||||||||
| 2018 | 385 | 11 | 428 | 534 | 24.5 | 700 | ||||||||||
| 2017 | 338 | 21.3 | 425 | 558 | 19.3 | 684 | ||||||||||
| 2016 | 349 | 19.7 | 430 | 577 | 18.1 | 697 | ||||||||||
| 2015 | 389 | 9.6 | 426 | 580 | 17.2 | 693 | ||||||||||
| 2014 | 372 | 12.8 | 422 | 556 | 20 | 688 | ||||||||||
i=imputed
NOTES:
- 1. This table only show data for past 10 years from each survey.
- 2. See TableBuilder for the prior year data.
- 3. Blank white cells indicate data not available, not applicable, or institution not eligible for survey.
- 4. Data from the Survey of Science and Engineering Research Facilities is collected every two years.
Selected data for this institution are provided in the profile tables listed below.
| Data Tables |
|---|
| Earned doctorates: 2023–14 |
| by trend major field of study |
| Graduate students in science, engineering, and health: 2023–14 |
| by characteristic |
| full-time students |
| part-time students |
| full-time students with financial support |
| from federal sources, by field |
| by type and source of support |
| Postdoctorates in science, engineering, and health: 2023–14 |
| by characteristic |
| federally supported |
| R&D expenditures |
| total |
| by field: 2023–14 |
| by source of funds and R&D field: 2023 |
| federally funded, by agency: 2023–14 |
| head count of R&D personnel: 2023–17 [temporarily discontinued] |
